1. Home
  2. PACB vs SRDX Comparison

PACB vs SRDX Comparison

Compare PACB & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • SRDX
  • Stock Information
  • Founded
  • PACB 2000
  • SRDX 1979
  • Country
  • PACB United States
  • SRDX United States
  • Employees
  • PACB N/A
  • SRDX N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • SRDX Medical/Dental Instruments
  • Sector
  • PACB Industrials
  • SRDX Health Care
  • Exchange
  • PACB Nasdaq
  • SRDX Nasdaq
  • Market Cap
  • PACB 364.2M
  • SRDX 416.1M
  • IPO Year
  • PACB 2010
  • SRDX 1998
  • Fundamental
  • Price
  • PACB $1.27
  • SRDX $29.00
  • Analyst Decision
  • PACB Buy
  • SRDX Buy
  • Analyst Count
  • PACB 8
  • SRDX 2
  • Target Price
  • PACB $2.13
  • SRDX $43.00
  • AVG Volume (30 Days)
  • PACB 10.4M
  • SRDX 69.7K
  • Earning Date
  • PACB 08-06-2025
  • SRDX 07-30-2025
  • Dividend Yield
  • PACB N/A
  • SRDX N/A
  • EPS Growth
  • PACB N/A
  • SRDX N/A
  • EPS
  • PACB N/A
  • SRDX N/A
  • Revenue
  • PACB $152,357,000.00
  • SRDX $121,575,000.00
  • Revenue This Year
  • PACB $3.33
  • SRDX N/A
  • Revenue Next Year
  • PACB $18.52
  • SRDX $3.70
  • P/E Ratio
  • PACB N/A
  • SRDX N/A
  • Revenue Growth
  • PACB N/A
  • SRDX N/A
  • 52 Week Low
  • PACB $0.85
  • SRDX $26.00
  • 52 Week High
  • PACB $2.72
  • SRDX $42.44
  • Technical
  • Relative Strength Index (RSI)
  • PACB 59.90
  • SRDX 48.86
  • Support Level
  • PACB $1.25
  • SRDX $28.67
  • Resistance Level
  • PACB $1.40
  • SRDX $29.87
  • Average True Range (ATR)
  • PACB 0.11
  • SRDX 0.75
  • MACD
  • PACB 0.03
  • SRDX -0.05
  • Stochastic Oscillator
  • PACB 73.95
  • SRDX 26.60

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

Share on Social Networks: